Covered recipient · General Payments record
RACHEL AMANDA ALVIDREZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$1,310.08
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $545.41 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $164.35 | 5 |
| Alexion Pharmaceuticals, Inc. | $119.28 | 1 |
| Amgen Inc. | $118.82 | 1 |
| Horizon Pharma plc | $111.62 | 1 |
| Lilly USA, LLC | $31.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $119.28 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017076067 | CMS |
| Amgen Inc. | $118.82 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020474093 | CMS |
| GlaxoSmithKline, LLC. | $6.70 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003979315 | CMS |
| GlaxoSmithKline, LLC. | $18.12 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003979323 | CMS |
| GlaxoSmithKline, LLC. | $5.13 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003979309 | CMS |
| GlaxoSmithKline, LLC. | $111.43 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003979297 | CMS |
| GlaxoSmithKline, LLC. | $22.97 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003979303 | CMS |
| Horizon Therapeutics plc | $111.62 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987094827 | CMS |
| Lilly USA, LLC | $31.34 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033224987 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.